List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 880 studies with search of:   United States, Delaware
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
2 Active, not recruiting Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza
Condition: Pain
Intervention: Drug: morphine sulfate extended release capsules
3 Active, not recruiting Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
Condition: Kidney Cancer
Interventions: Drug: bevacizumab;   Drug: recombinant interferon alfa
4 Active, not recruiting Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: calcium carbonate;   Drug: calcium citrate;   Drug: calcium gluconate;   Drug: cholecalciferol;   Drug: zoledronic acid;   Procedure: adjuvant therapy
5 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
6 Active, not recruiting Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Condition: Breast Cancer
Interventions: Drug: raloxifene;   Drug: tamoxifen citrate
7 Active, not recruiting Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
Condition: Kidney Cancer
Intervention: Drug: erlotinib hydrochloride
8 Active, not recruiting Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Procedure: conventional surgery;   Procedure: radiation therapy
9 Active, not recruiting Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium
10 Completed Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Cancer-Related Problem/Condition;   Lung Cancer
Interventions: Drug: cisplatin;   Drug: darbepoetin alfa;   Drug: dimesna;   Drug: docetaxel;   Drug: pegfilgrastim
11 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
12 Active, not recruiting A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Lung Neoplasms
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: SU011248
13 Recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid;   Osteoarthritis
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
14 Active, not recruiting Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: etoposide;   Drug: irinotecan hydrochloride;   Procedure: radiation therapy
15 Completed FR901228 in Treating Patients With Recurrent Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: romidepsin
16 Active, not recruiting Sorafenib in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: sorafenib tosylate
17 Completed Combination Chemotherapy in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel
18 Recruiting Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: observation
19 Recruiting Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)
Condition: Carcinoma, Renal Cell
Interventions: Drug: Sunitinib Malate Continuous Daily Dosing;   Drug: Sunitinib Malate Schedule 4/2
20 Recruiting Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: cetuximab;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services